Fusion Pharmaceuticals Inc (FUSN) is near the top in its industry group according to InvestorsObserver. FUSN gets an overall rating of 85. That means it scores higher than 85 percent of stocks. Fusion Pharmaceuticals Inc gets a 99 rank in the Biotechnology industry. Biotechnology is number 71 out of 148 industries.
FUSN has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on FUSN!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 85 means the stock is more attractive than 85 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Fusion Pharmaceuticals Inc Stock Today?
Fusion Pharmaceuticals Inc (FUSN) stock is higher by 1.09% while the S&P 500 has fallen -1.35% as of 2:05 PM on Wednesday, Oct 25. FUSN is higher by $0.04 from the previous closing price of $3.99 on volume of 4,601 shares. Over the past year the S&P 500 is higher by 8.58% while FUSN is higher by 79.11%. FUSN lost -$1.93 per share the over the last 12 months.
Click Here to get the full Stock Report for Fusion Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
